ストックスクリーナーアプリを入手
2.4959
0.16%
-0.0041
前日終値:
$2.50
開ける：
$2.5
24時間の取引高:
5,507
Relative Volume:
0.00
時価総額：
$20.21M
収益：
$34.75M
当期純損益:
$-24.76M
株価収益率:
-0.208
EPS:
-12
ネットキャッシュフロー:
$-50.91M
1週間 パフォーマンス:
+7.58%
1か月 パフォーマンス:
-10.22%
6か月 パフォーマンス:
-77.04%
1年 パフォーマンス:
-92.32%
1日の値動き範囲:
$2.4406
$2.50
1週間の範囲:
$2.30
$2.66
52週間の値動き範囲:
$2.15
$33.75
Allurion Technologies Inc Stock (ALUR) Company Profile
ALUR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ALUR
Allurion Technologies Inc
|
2.4959 | 20.21M | 34.75M | -24.76M | -50.91M | -12.00 |
|
ABT
Abbott Laboratories
|
134.51 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
106.29 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
393.45 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
86.00 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.28 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Allurion Technologies Inc Stock (ALUR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-14 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2024-10-02 | 開始されました | TD Cowen | Buy |
| 2024-09-06 | 開始されました | ROTH MKM | Buy |
| 2024-02-09 | 開始されました | Jefferies | Buy |
Allurion Technologies Inc (ALUR) 最新ニュース
Major Weight Loss Breakthrough: 20,000 Patient Study Reveals Muscle-Preserving Success of Allurion Program - Stock Titan
Allurion Announces Findings from New Studies on Muscle Mass Maintenance in Nearly 20,000 Patients and Four-Year Weight Loss Outcomes at the 2025 Annual Meeting of the ASMBS - New Castle News
Allurion Technologies Inc. (NYSE:ALUR) Short Interest Down 42.4% in May - Defense World
(ALUR) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Allurion Technologies (NYSE:ALUR) Trading 2.1% Higher – Time to Buy? - Defense World
Allurion at Jefferies Conference: Strategic US Market Entry By Investing.com - Investing.com South Africa
Allurion at Jefferies Conference: Strategic US Market Entry - Investing.com Australia
October's 4 Best Penny Stocks: High-Risk, High-Reward Picks - The Globe and Mail
Allurion to Present at Jefferies Global Healthcare Conference - BioSpace
When the Price of (ALUR) Talks, People Listen - news.stocktradersdaily.com
ALURALLURION TECHNOLOGIES INC Latest Stock News & Market Updates - Stock Titan
Allurion Technologies Inc. (ALUR) Returns to France with 12.2% Weight Loss, 6.6% Muscle Gain Results - MSN
Allurion Presents Data on Increasing Muscle Mass and Decreasing Fat Mass in Patients Treated With the Allurion Program - BioSpace
Allurion Weight Loss Program Builds Muscle Mass 6.6%, Cuts Fat 11% in Clinical Study | ALUR Stock News - Stock Titan
Zacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion Technologies - Yahoo Finance
4 Medical Product Stocks to Watch From a Challenging Industry - Yahoo Finance
Trend Tracker for (ALUR) - news.stocktradersdaily.com
Research Analysts Offer Predictions for ALUR FY2025 Earnings - Defense World
Yale University's Strategic Exit from Allurion Technologies Inc: A 13F Filing Insight - GuruFocus
Allurion Technologies Earnings Call: Transition and Growth - TipRanks
Allurion outlines path to FDA submission and expects revenue ramp as B2B2C strategy expands in 2025 - MSN
Allurion Technologies, Inc. (ALUR) Q1 Earnings Beat Estimates - MSN
Allurion Technologies Inc (ALUR) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance
Allurion Technologies Reports Q1 2025 Financial Results - TipRanks
Allurion Technologies (ALUR) Unveils Promising Obesity Treatment Results | ALUR Stock News - GuruFocus
Allurion Technologies (ALUR) Q1 2025 Results Highlight Revenue a - GuruFocus
Transcript : Allurion Technologies Inc., Q1 2025 Earnings Call, May 14, 2025 - marketscreener.com
What To Expect From Allurion Technologies Inc (ALUR) Q1 2025 Ear - GuruFocus
Allurion To File Final Module Of Weight Loss Balloon To FDA For Approval Next Month - Nasdaq
Allurion Technologies (ALUR) Surges Over 50% Following Data Pres - GuruFocus
Earnings call transcript: Allurion Technologies Q1 2025 sees revenue drop, stock surges - Investing.com
Allurion Technologies Inc. (NYSE:ALUR) Q1 2025 Earnings Call Transcript - MSN
ALUR Reports Q1 Revenue Exceeding Expectations, Anticipates Prom - GuruFocus
Allurion Technologies Q1 2025 Financial Results - TradingView
ALUR Reports Q1 Revenue Exceeding Expectations, Anticipates Promising Year | ALUR Stock News - GuruFocus
Allurion Technologies reports Q1 EPS 20c vs. ($2.78) last year - TipRanks
Allurion Reports First Quarter 2025 Financial Results and Provides Business Update - marketscreener.com
After-Market Rally For Allurion (ALUR) As New Data Sparks Investor Optimism - Stocks Telegraph
Allurion Presents Data on the Allurion Balloon and AI-Powered Virtual Care Suite with and without GLP-1s to Optimize Muscle Mass and Increase Weight Loss - 01net
Allurion reports weight loss breakthrough at obesity congress - Investing.com Australia
Allurion reports weight loss breakthrough at obesity congress By Investing.com - Investing.com Nigeria
New Clinical Data: Allurion's Swallowable Balloon Supercharges GLP-1 Weight Loss Results, Preserves Muscle - Stock Titan
Allurion Technologies Inc (ALUR) 財務データ
収益
当期純利益
現金流量
EPS
Allurion Technologies Inc (ALUR) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Gaur Shantanu | Chief Executive Officer |
Mar 28 '25 |
Buy |
3.35 |
8,000 |
26,800 |
8,000 |
0.23%
0.36%
大文字化:
|
ボリューム (24 時間):